1. Home
  2. LVTX vs RDI Comparison

LVTX vs RDI Comparison

Compare LVTX & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LVTX
  • RDI
  • Stock Information
  • Founded
  • LVTX 2016
  • RDI 1937
  • Country
  • LVTX Netherlands
  • RDI United States
  • Employees
  • LVTX N/A
  • RDI N/A
  • Industry
  • LVTX Biotechnology: Pharmaceutical Preparations
  • RDI Movies/Entertainment
  • Sector
  • LVTX Health Care
  • RDI Consumer Discretionary
  • Exchange
  • LVTX Nasdaq
  • RDI Nasdaq
  • Market Cap
  • LVTX 34.2M
  • RDI 30.1M
  • IPO Year
  • LVTX 2021
  • RDI N/A
  • Fundamental
  • Price
  • LVTX $1.31
  • RDI $1.25
  • Analyst Decision
  • LVTX Hold
  • RDI Hold
  • Analyst Count
  • LVTX 3
  • RDI 1
  • Target Price
  • LVTX $3.17
  • RDI $2.40
  • AVG Volume (30 Days)
  • LVTX 61.1K
  • RDI 42.0K
  • Earning Date
  • LVTX 05-20-2025
  • RDI 05-14-2025
  • Dividend Yield
  • LVTX N/A
  • RDI N/A
  • EPS Growth
  • LVTX N/A
  • RDI N/A
  • EPS
  • LVTX N/A
  • RDI N/A
  • Revenue
  • LVTX $11,982,000.00
  • RDI $210,527,000.00
  • Revenue This Year
  • LVTX N/A
  • RDI $11.97
  • Revenue Next Year
  • LVTX N/A
  • RDI $6.40
  • P/E Ratio
  • LVTX N/A
  • RDI N/A
  • Revenue Growth
  • LVTX 77.01
  • RDI N/A
  • 52 Week Low
  • LVTX $0.85
  • RDI $1.17
  • 52 Week High
  • LVTX $3.20
  • RDI $1.89
  • Technical
  • Relative Strength Index (RSI)
  • LVTX 61.39
  • RDI 45.11
  • Support Level
  • LVTX $1.03
  • RDI $1.18
  • Resistance Level
  • LVTX $1.20
  • RDI $1.28
  • Average True Range (ATR)
  • LVTX 0.08
  • RDI 0.08
  • MACD
  • LVTX 0.00
  • RDI 0.00
  • Stochastic Oscillator
  • LVTX 87.50
  • RDI 25.00

About LVTX LAVA Therapeutics N.V.

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.

Share on Social Networks: